INS and depressive symptom measurement: (7) Treatment Regimen (19, 49): Patients using both insulin and oral agents had a significantly higher depression risk (AOR = 1.44; 95% CI: 1.01–2.06), while insulin-only users did not (AOR = 1.42; 95% CI: 0.81–2.5).